Pharmaceutical Industry Information Portal


All posts by tag


A Clinical Trial of a Russian Originator for the Treatment of Cervical Cancer Started in China

A joint venture between the biotechnology company BIOCAD and Shanghai Pharmaceuticals Holding has announced the enrollment of the first patient in a trial of...

BIOCAD has presented the results of efficacy evaluation of the Russian immuno-oncology product prolgolimab for the treatment of melanoma

In the evening of June 21, 2021, leading Russian and international cancer experts presented the results of a three-year efficacy study of the Russian...

Expert Articles